In vivo imaging plays an essential role within medicine, pharmaceutics and biology. Imaging with fluorescent tracers is one promising approach, as multiple tracer types are available to simultaneously ...

PHILADELPHIA, Sept. 24 /PRNewswire/ -- Today Astellas Pharma US, Inc. ("Astellas") announced the Launch of the Appropriate Use Criteria (AUC) for Cardiac Radionuclide Imaging application (app) for ...

Thyroid radioiodine imaging should not be routinely performed in patients with hyperthyroidism, new data reveal, as these scans provide little additional information over standard clinical and ...

A new molecular imaging radiotracer can precisely diagnose a variety of cancers, providing a roadmap to identify patients who may benefit from targeted radionuclide therapies. In the largest medical ...

Initiation of Phase 1/2 clinical study of novel peptide-targeted radionuclide therapy and imaging agent targeting fibroblast activation protein (FAP) expected 1H 2021 Will be the first ...

Transaxial slices of baseline positron emission tomography (PET) and fused PET/magnetic resonance imaging (MRI; left) demonstrate a somatostatin receptor-expressing meningioma in the left cavernous ...

Become familiar with the appropriate use of [18F]FDG PET/CT in patients with gynecological malignancies. Understand the rationale of using [18F]FDG PET/CT at various stages during the course of ...

Click on the 'Visit E-Learning Course' button on the top. Sign in with your NUCLEUS account, then click on 'Enrol me' on the bottom. If you do not have a NUCLEUS account, please register here first.

Reston, VA (September 28, 2021)—A promising radionuclide treatment may offer new therapeutic options for breast cancer patients, according to research published in The Journal of Nuclear Medicine. The ...

Parkinson's disease affects more than 1.1 million people in the United States, progressively damaging the brain cells that control movement. By the time symptoms like tremors appear, patients have ...